Save the Date - March 14-16, 2011

Download the Final Program

SCOPE

Rising rates of obesity and other cardiometabolic risk factors, including dyslipidemia, have led to an increased prevalence of diabetes and atherosclerotic disease around the world, especially in countries undergoing rapid economic growth such as Qatar. The purpose of the XVII International DALM Symposium on Diabetes, Obesity, and the Metabolic Syndrome is to update physicians, particularly those practicing in the Middle East, on recent research regarding the prevention and pharmacological treatment of diabetes, obesity, and related cardiometabolic disorders.

This international symposium will facilitate open discussion and peer-to-peer dialogue among health care providers and experts from both the Middle East and the larger global community. As a forum for cross-cultural scientific exchange, it will enhance our understanding of the genetic, ethnic, environmental, epidemiological, and sociocultural determinants of metabolic disease.

Topics to be discussed include:

• Lifestyle and dietary modifications in patients with or at risk for diabetes, obesity, and the metabolic syndrome
• Diagnosis and pharmacological treatment of diabetes, obesity, and cardiometabolic risk factors, including lipid abnormalities
• Latest basic research findings and clinical trials
• Applicability of international prevention and treatment guidelines for populations within the Middle East
• Economic and public health challenges surrounding diabetes, obesity, and the metabolic syndrome
• Clinical experience with treating women, young people, and the elderly
• Novel risk factors, emerging biomarkers, and genetic testing

TARGET AUDIENCE

The symposium is designed for a multidisciplinary audience, particularly physicians and health care practitioners in the fields of cardiology, diabetology, endocrinology, epidemiology, family medicine, genetic medicine, geriatrics, internal medicine, lipidology, pediatrics, primary care, and public health.  Basic scientists, clinical researchers, and representatives from health regulatory agencies and industry will also benefit from the scientific, clinical, and economic discussions during the conference.

KEY DATES

• Call for Abstracts: Now Closed
• Registration & Housing : Now Available
• Abstract Submission deadline: December 13, 2010

CHAIRPERSONS

Antonio Gotto, Jr, MD, DPhil
Weill Cornell Medical College
New York, NY, USA

Rodolfo Paoletti, MD
Giovanni Lorenzini Medical Foundation
Milan, Italy and Houston, TX, USA

Javaid Sheikh, MD
Weill Cornell Medical College in Qatar
Doha, Qatar

FOR MORE INFORMATION

Join our mailing list to be notified when the Call for Abstracts, Registration & Housing, and Scientific Program become available.

Or, contact DALM 2011 at:

6535 Fannin, MS A-601
Houston, TX, 77030 (USA)
dalm@bcm.edu

Via A. Appiani 7
20121 Milan (Italy)
dalm@lorenzinifoundation.org